Jennifer Evans, MS

Data Manager, Benioff Homelessness and Housing Initiative

Jennifer Evans is a Research Data Analyst at the Center for Vulnerable Populations (CVP) and the new Benioff Homelessness and Housing Initiative. She will be working with Dr. Margot Kushel on research studies focusing on homelessness and its effects on health. She has over 20 years of experience at UCSF providing statistical support to various epidemiologic studies. Most recently she served as principal statistician within Global Health Sciences focusing on the epidemiology of HIV and hepatitis C virus (HCV) infections in marginalized populations. She holds a Master of Science in Epidemiology from the University of Massachusetts and a Bachelor of Arts in Sociology and Spanish from Tufts University.
Publications
  1. Housing Stability and Hepatitis C Infection for Young Adults Who Inject Drugs: Examining the Relationship of Consistent and Intermittent Housing Status on HCV Infection Risk.
  2. Syndemic Psychosocial Health Conditions Associated with Recent Client-Perpetrated Violence Against Female Entertainment and Sex Workers in Cambodia.
  3. Who's that SMARTgirl? Reaching Cambodian Female Entertainment and Sex Workers with HIV Prevention Services.
  4. Chronic Human Pegivirus 2 without Hepatitis C Virus Co-infection.
  5. HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco.
  6. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine.
  7. Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison.
  8. Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships.
  9. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated.
  10. Randomized controlled trial of a positive affect intervention for methamphetamine users.
  11. Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
  12. Proportion and predictors of loss to follow-up in a longitudinal cohort study of female entertainment and sex workers in Cambodia.
  13. High pregnancy incidence and low contraceptive use among a prospective cohort of female entertainment and sex workers in Phnom Penh, Cambodia.
  14. Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
  15. Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement.
  16. Urban and Rural Adolescents' Points-of-Access for Alcohol and Tobacco.
  17. A Study of Sexual Relationship Power among Young Women Who Inject Drugs and Their Sexual Partners.
  18. HIV treatment cascade among female entertainment and sex workers in Cambodia: impact of amphetamine use and an HIV prevention program.
  19. HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California.
  20. Protocol of a cluster randomised stepped-wedge trial of behavioural interventions targeting amphetamine-type stimulant use and sexual risk among female entertainment and sex workers in Cambodia.
  21. A Longitudinal Study of Multiple Drug Use and Overdose Among Young People Who Inject Drugs.
  22. The impact of violence on sex risk and drug use behaviors among women engaged in sex work in Phnom Penh, Cambodia.
  23. Behavioral interventions for Cambodian female entertainment and sex workers who use amphetamine-type stimulants.
  24. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA.
  25. Human papillomavirus knowledge, vaccine acceptance, and vaccine series completion among female entertainment and sex workers in Phnom Penh, Cambodia: the Young Women's Health Study.
  26. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
  27. Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA.
  28. Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs.
  29. Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users.
  30. Biomarker validation of recent unprotected sexual intercourse in a prospective study of young women engaged in sex work in Phnom Penh, Cambodia.
  31. Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics.
  32. Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.
  33. Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection.
  34. Declining sexually transmitted infections among female sex workers: the results of an HIV and sexually transmitted infection prevention strategy in Honduras, 2006-08.
  35. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study.
  36. Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia.
  37. HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.
  38. Are young injection drug users ready and willing to participate in preventive HCV vaccine trials?
  39. Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain.
  40. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.
  41. Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco.
  42. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study).
  43. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco.
  44. Revolving doors: imprisonment among the homeless and marginally housed population.
  45. Heroin overdose among young injection drug users in San Francisco.
  46. No door to lock: victimization among homeless and marginally housed persons.
  47. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study.
  48. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study).
  49. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study.
  50. Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco.
  51. Hepatitis C virus seroconversion among young injection drug users: relationships and risks.
  52. Factors associated with repeat mammography in a New York State public health screening program.